Polar Capital Holdings’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8M Sell
158,843
-14,483
-8% -$1.58M 0.06% 162
2026
Q1
$16M Buy
173,326
+15,841
+10% +$1.59M 0.06% 158
2025
Q4
$16.1M Buy
+157,485
New +$14.1M 0.06% 169
2023
Q3
Sell
-10,010
Closed -$358K 288
2023
Q2
$358K Buy
+10,010
New +$287K ﹤0.01% 277
2022
Q3
Sell
-36,690
Closed -$1.48M 427
2022
Q2
$1.48M Sell
36,690
-30,507
-45% -$1.51M 0.01% 287
2022
Q1
$4.45M Sell
67,197
-63,261
-48% -$4.33M 0.02% 277
2021
Q4
$13M Sell
130,458
-437,951
-77% -$45.3M 0.05% 209
2021
Q3
$71.1M Sell
568,409
-91,135
-14% -$10.8M 0.29% 83
2021
Q2
$81.9M Sell
659,544
-34,924
-5% -$4.7M 0.36% 65
2021
Q1
$106M Buy
+694,468
New +$105M 0.66% 43

Other funds holding GH

Polar Capital Holdings's GH Position: Q2 2026 in Review

Polar Capital Holdings reduced its Guardant Health (GH) stake by 8.4% in Q2 2026, selling an estimated $1.58M and leaving 158,843 shares worth $23.8M. The position accounts for 0.06% of the portfolio, ranked #162.

Polar Capital Holdings first reported a position in GH in Q1 2021 and has held it in 10 quarters since. The position peaked at $106M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Polar Capital Holdings held 158,843 shares of Guardant Health worth $23.8M as of Q2 2026.
  • Polar Capital Holdings sold 14,483 Guardant Health shares in Q2 2026, an estimated $1.58M.
  • Guardant Health made up 0.06% of Polar Capital Holdings's portfolio in Q2 2026, its #162 holding.
  • Polar Capital Holdings first reported a position in Guardant Health in Q1 2021 and has held it in 10 quarters since.
  • Polar Capital Holdings's Guardant Health position peaked at $106M in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.